Dextroamphetamine Sulfate Tablets, 10 mg:
ETHEX Corporation announced the recall of specific lots of certain generic products that it markets due to the possibility of oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient, which could result in patients receiving as much as about twice the expected dosage of these drugs. Overdoses of Propafenone HCl, Isosorbide Mononitrate, Morphine sulfate and Dextroamphetamine Sulfate can have serious or life-threatening consequences. In the case of Propafenone HCl, these consequences can include arrhythmias (irregular heartbeat) and low blood pressure. In the case of Isosorbide Mononitrate, these consequences can include fainting and low blood pressure. In the case of Morphine Sulfate, these consequences can include respiratory depression (difficulty or lack of breathing) and low blood pressure. In the case of Dextroamphetamine Sulfate, these consequences can include rapid heart rate and high blood pressure. The lots involved in the recall were all shipped prior to May 22, 2008 and are Dextroamphetamine Sulfate Tablets, 10 mg: Lots: 73934, 75892, 77945, 81137, 86320 with expiration dates ranging from 6/2009 to 5/2011.
If you are interested in retaining either a product liability lawyer or a class action attorney Click here.
For more resources regarding the ETHEX Corporation Dextroamphetamine Sulfate Tablets, 10 mg: recall issue click here
|